Nanologica AB (publ) (NICA.ST)
Nasdaq Stockholm · Financial statements, TTM figures and earnings dates
In fiscal year 2024 (ended December 31, 2024), Nanologica AB (publ) reported revenue of SEK 14.5M and net income of −SEK 65.6M. Annual financial statements are available for fiscal years 2022 to 2024, taken from the company's ESEF annual reports (IFRS).
Open interactive financials →Key financials
| SEK | FY2024 2024-12-31 | FY2023 2023-12-31 | FY2022 2022-12-31 |
|---|---|---|---|
| Income statement | |||
| Revenue | SEK 14.5M | SEK 1.4M | SEK 1.6M |
| Operating income | −SEK 59.3M | −SEK 70.0M | −SEK 50.9M |
| Net income | −SEK 65.6M | −SEK 75.2M | −SEK 55.2M |
| Diluted EPS | −SEK 1.32 | −SEK 2.08 | −SEK 1.84 |
| Cash flow | |||
| Operating cash flow | −SEK 80.7M | −SEK 35.8M | −SEK 45.2M |
| Capital expenditure | SEK 262.0K | SEK 1.8M | SEK 1.6M |
| Free cash flow | −SEK 81.0M | −SEK 37.6M | −SEK 46.8M |
| Balance sheet | |||
| Cash and equivalents | SEK 48.4M | SEK 10.1M | SEK 70.3M |
| Total assets | SEK 143.1M | SEK 77.4M | SEK 154.5M |
| Total liabilities | SEK 69.0M | SEK 79.3M | SEK 81.4M |
| Total debt | SEK 24.0K | SEK 66.8M | SEK 66.6M |
| Shareholders' equity | SEK 74.1M | −SEK 1.9M | SEK 73.2M |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in SEK as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full NICA.ST page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open NICA.ST financials →